Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Venous Thromboembolism × Fondaparinux × Clear all

Phase

Phase NA 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Classical hematology 1

Conditions

Venous Thromboembolism 1 Ovarian Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

apixaban 1 Tacrolimus 1 Gemcitabine 1 Fondaparinux 1 Drug Therapy 1 Cyclosporine 1 ALT-836 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00476216 2014-03-05

Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer

University of Alabama at Birmingham

Phase 1 Completed

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡